| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
| 01/20/2009 | CA2331758C Method for the stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 01/20/2009 | CA2325526C Aryl phenyl substituted cyclic ketoenols |
| 01/20/2009 | CA2235797C Process for purification of almost completely anhydrous organic liquids |
| 01/15/2009 | WO2009008913A2 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease |
| 01/15/2009 | WO2009007396A1 Nonsteroidal progesterone receptor modulators |
| 01/15/2009 | WO2008140251A3 Cyclooxygenase-2 inhibitors |
| 01/15/2009 | WO2008132142A3 New heterocyclic derivatives useful for the treatment of cns disorders |
| 01/15/2009 | WO2008101914A3 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 01/15/2009 | US20090018311 Methods and compounds for producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 01/15/2009 | US20090018183 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/15/2009 | US20090018182 Crystalline forms of atorvastatin |
| 01/15/2009 | US20090018167 angiogenesis inhibitors such as 1-phenyl-3-pyridin-2-ylprop-2-en-1-one, having antitumor and anticarcinogenic activity; treatment of skin disorders such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, and lymphangiogenesis, as well as chronic inflammatory disease such as arthritis |
| 01/15/2009 | US20090018116 Therapeutic Compounds |
| 01/15/2009 | US20090018058 Vitamin D Receptor Modulators |
| 01/15/2009 | US20090017489 Methods For Modulating The Development Of Dopamine Neuron By The Dopamine D2 Receptor And Compositions Thereof |
| 01/15/2009 | US20090017004 Polymeric drug delivery systems containing an aromatic allylic acid |
| 01/15/2009 | DE112007000484T5 Stabil isotopenmarkierte aliphatische Aminosäuren, Verfahren zum Einbringen von diesen in ein Zielprotein und Verfahren zur NMR-Konformationsanalyse von Proteinen Stable isotope-labeled aliphatic amino acids, methods for introducing these into a target protein, and NMR method for the conformation of proteins |
| 01/15/2009 | CA2681624A1 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease |
| 01/14/2009 | EP2014645A1 Pleuromutilin derivatives and their use as antimicrobials |
| 01/14/2009 | EP2014285A1 NPYY5 antagonists |
| 01/14/2009 | EP2013168A1 Alkoxyalkyl-substituted cyclic ketoenols |
| 01/14/2009 | EP2013167A2 Total synthesis of salinosporamide a and analogs thereof |
| 01/14/2009 | EP2013166A2 N-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone, method of its preparation and pharmaceutical use |
| 01/14/2009 | EP2013163A1 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 01/14/2009 | EP1809600A4 Cyclic b-amino acid derivatives as factor xa inhibitors |
| 01/14/2009 | EP1567518B1 Oxime ester photoinitiators with heteroaromatic groups |
| 01/14/2009 | EP1463728B1 Fused cyclic modulators of nuclear hormone receptor function |
| 01/14/2009 | CN101346351A Alkoxyalkyl spirocyclic tetramic acids and tetronic acids |
| 01/14/2009 | CN101346350A Method for production of heteroaromatic ring compound having n-rf group |
| 01/14/2009 | CN100450994C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 01/13/2009 | US7476747 Substituted gamma lactams as therapeutic agents |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
| 01/13/2009 | US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 01/13/2009 | US7476672 Acetylenic compounds useful in treating inflammatory disorders |
| 01/13/2009 | CA2271276C Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments |
| 01/08/2009 | WO2008119457A3 Lactam-substituted dicarboxylic acids and use thereof |
| 01/08/2009 | WO2008109055A8 Cyanopyrrole sulfonamides useful for modulation of the progesterone receptor |
| 01/08/2009 | US20090012314 Process for Production of Lasofoxifene or Analogue Thereof |
| 01/08/2009 | US20090012313 3-Carboxy-2-Oxo-1-Pyrrolidine Derivatives and Their Uses |
| 01/08/2009 | US20090012312 Process for Preparing Pyrrole Derivatives and Intermediates |
| 01/08/2009 | US20090012151 Novel Compounds 951 |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012144 Optically active 2,5-bisaryl-delta¹ -pyrrolines and their use as pest control agents |
| 01/08/2009 | US20090012120 Synthesis of N-heterocycles, beta-amino acids, and allyl amines via aza-payne mediated reaction of ylides and hydroxy aziridines |
| 01/08/2009 | US20090012070 Pesticidal heterocycles |
| 01/08/2009 | US20090010860 used for protecting human hair and skin against the damaging effect of ultraviolet radiation |
| 01/08/2009 | CA2692145A1 Antiviral compounds |
| 01/07/2009 | EP2011800A2 Inhibitors of caspase |
| 01/07/2009 | EP2010486A2 Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods |
| 01/07/2009 | EP2010477A2 Poly (ethylene glycol) containing chemically disparate endgroups |
| 01/07/2009 | EP2010475A2 Heterofunctional poly(ethylene glycol) containing acid-labile amino protecting groups and uses thereof |
| 01/07/2009 | EP1928821B1 Carboxamide derivatives as muscarinic receptor antagonists |
| 01/07/2009 | EP1807072B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/07/2009 | EP1667966A4 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 01/07/2009 | EP1569916B1 Substituted aralkyl derivatives |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1345896B1 Crystalline forms of atorvastatin |
| 01/07/2009 | CN101340959A Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound |
| 01/07/2009 | CN101337920A Phenylalanyl pyrrolidine derivates, preparation method and application thereof |
| 01/07/2009 | CN100448877C 3-phenyl substituted 3-substituted-4ketolactams and ketolactones |
| 01/07/2009 | CN100448876C Heterocyclocarboxamide derivatives |
| 01/06/2009 | US7473795 Blends of quinone alkide and nitroxyl compounds as polymerization inhibitors |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/06/2009 | US7473703 e.g. N-(4-{1-Hydroxy-1-[1-(2-methoxyethyl)-1H-pyrrol-2-yl]-ethyl}-phenyl)-N-methyl-benzenesulfonamide; liver X receptor (LXR) agonist; antidiabetic, antiproliferative agent; lipid, metabolic disorders, obesity, diabetes, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia |
| 01/06/2009 | CA2421008C Substituted heterocyclic compounds for treating multidrug resistance |
| 01/06/2009 | CA2414095C Novel compounds |
| 01/06/2009 | CA2391357C A process for producing crystalline atorvastatin calcium |
| 01/06/2009 | CA2295446C Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 01/06/2009 | CA2169219C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them |
| 01/01/2009 | US20090005577 Method of producing 1-substituted 3-pyrrolates |
| 01/01/2009 | US20090005576 Production Method of Optically Active Cyclohexane Ether Compounds |
| 01/01/2009 | US20090005574 reacting a 9-hydroxymethyl-2-amino fluorene with a silyl protecting reagent e.g. tert-butyldimethylsilyl chloride to form tert-butyldimethylsiloxy-9-methyl-2-aminofluorene, reacting intermediate with 3-maleimidopropionic acid; protecting; chemical intermediates for protein and peptide drugs |
| 01/01/2009 | US20090005542 Hydrolysable polymeric FMOC- linker |
| 01/01/2009 | US20090005410 N-(4-Chloro-2-[1,2,3]triazolo[4,5-b]pyridin-1-yl-phenyl)-4-(1-hydroxy-1-methyl-ethyl)-benzene-sulfonamide sodium salt, used as chemokine receptors antagonists, useful for treating inflammation |
| 01/01/2009 | US20090004641 Site-specific labeling of affinity peptides in fusion proteins |
| 01/01/2009 | US20090004140 4-substituted pyrrolidine as anti-infectives |
| 12/31/2008 | WO2009002203A1 Polyfunctional fullerene c60 aminoacid derivatives |
| 12/31/2008 | WO2009001127A1 Cyanocyclopropylcarboxamides as cathepsin inhibitors |
| 12/31/2008 | WO2009000878A1 Kallikrein 7 modulators |
| 12/31/2008 | WO2009000523A1 Method for preparing fmoc-based hydrolysable linkers |
| 12/31/2008 | WO2009000049A1 Intrinsically conducting polymers |
| 12/31/2008 | WO2008132139A3 New heterocyclic derivatives useful for the treatment of cns disorders |
| 12/31/2008 | WO2008053221A3 Process for preparing indol- 5 -oxy- quinazoline derivatives and intermediates |
| 12/31/2008 | WO2008014381A3 Modulators of chemokine receptor activity, crystalline forms and process |
| 12/31/2008 | WO2008014360A3 Modulators of chemokine receptor activity, crystalline forms and process |
| 12/31/2008 | EP2009010A1 Cocrystal of c-glycoside derivative and l-proline |
| 12/31/2008 | EP2008999A1 N-tert-butoxycarbonyl-2-pyrrolidinones and process for producing the same |
| 12/31/2008 | EP2008997A1 Process for production of ethylenediamine derivative having halogenated carbamate group and acyl group, and intermediated for production of the derivative |
| 12/31/2008 | EP2007749A2 Tetralines antagonists of the h-3 receptor |
| 12/31/2008 | EP2007745A2 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 12/31/2008 | EP2007720A1 Benzamide derivatives as inhibitors of histone deacetylase |
| 12/31/2008 | EP2007719A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 12/31/2008 | EP2007705A1 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use |
| 12/31/2008 | EP2007383A2 Inhibitors of protein prenyltransferases |
| 12/31/2008 | EP1851198B1 Substituted pyrroles, compositions containing same, method for making same and use thereof |
| 12/31/2008 | EP1051397B1 Method for preparing an n- (aliphatic or aromatic)carbonyl -2-aminoacetamide compound and a cyclyzed compound |
| 12/31/2008 | CN101336229A 改性的拟赖氨酸化合物 Proposed modification of lysine compound |